Journal article
Salivary gland dysfunction and nasolacrimal duct obstruction: stenotic changes following I-131 therapy
Ophthalmic plastic and reconstructive surgery, Vol.31(3), pp.e50-e52
05/2015
DOI: 10.1097/IOP.0000000000000066
PMID: 24836449
Abstract
Radioactive iodine has long been used in the treatment of cancers of the thyroid. While salivary complications secondary to I-131 therapy in association with xerophthalmia are well documented, there is little in the literature addressing simultaneous nasolacrimal duct obstruction with salivary gland dysfunction. The authors present 2 patients with epiphora from bilateral nasolacrimal duct obstruction and concurrent sialadenitis following I-131 ablation therapy for papillary thyroid carcinoma. These cases highlight the lacrimal and salivary duct complications resulting from I-131 therapy, introduce the possibility of a shared mechanism of damage, and demonstrate the availability of effective treatments for both conditions. Ophthalmologists see patients with epiphora from I-131 therapy and should be aware of the possible concurrent symptoms caused by salivary duct stenosis to make timely and appropriate referrals.
Details
- Title: Subtitle
- Salivary gland dysfunction and nasolacrimal duct obstruction: stenotic changes following I-131 therapy
- Creators
- Mack W Savage - University of IowaRachel K SobelHenry T HoffmanKeith D CarterMichael W FinkelsteinErin M Shriver
- Resource Type
- Journal article
- Publication Details
- Ophthalmic plastic and reconstructive surgery, Vol.31(3), pp.e50-e52
- Publisher
- United States
- DOI
- 10.1097/IOP.0000000000000066
- PMID
- 24836449
- ISSN
- 0740-9303
- eISSN
- 1537-2677
- Language
- English
- Date published
- 05/2015
- Academic Unit
- Radiation Oncology; Otolaryngology; Ophthalmology and Visual Sciences
- Record Identifier
- 9983980072502771
Metrics
13 Record Views